Revenue Recognition Segment revenue by major payor (Tables)

3 Months Ended

Mar. 31, 2025

Disaggregation of Revenue [Table Text Block]

The following tables summarize the Company's segment revenues by primary payor source:


	Three months ended March 31, 2025						Three months ended March 31, 2024
	U.S. dialysis		Other — Ancillary services		Consolidated		U.S. dialysis		Other — Ancillary services		Consolidated
Dialysis patient service revenues:
Medicare and Medicare Advantage	$	1,609,018	$		$	1,609,018	$	1,531,497	$		$	1,531,497
Medicaid and Managed Medicaid	206,509				206,509		210,123				210,123
Other government	76,746		209,747		286,493		82,587		145,785		228,372
Commercial	924,888		87,819		1,012,707		925,831		70,172		996,003
Other revenues:
Medicare and Medicare Advantage			98,954		98,954				103,110		103,110
Medicaid and Managed Medicaid			2		2				395		395
Commercial			2,701		2,701				6,940		6,940
Other(1)	6,008		15,599		21,607		6,122		15,203		21,325
Eliminations of intersegment revenues	(11,734)		(2,728)		(14,462)		(24,463)		(2,747)		(27,210)
Total	$	2,811,435	$	412,094	$	3,223,529	$	2,731,697	$	338,858	$	3,070,555

(1) Consists primarily of management service fees in the Company's U.S. dialysis business and research fees, management fees, and other non-patient service revenues in the Other - ancillary services businesses.